Literature DB >> 18077097

The Yin and Yang of lactosylceramide metabolism: implications in cell function.

Subroto Chatterjee1, Ambarish Pandey.   

Abstract

Although lactosylceramide (LacCer) plays a pivotal role in the biosynthesis of nearly all the major glycosphingolipids, its function in regulating cellular function has begun to emerge only recently. Our current opinion is that several physiologically critical molecules such as modified/oxidized LDL, growth factors, pro-inflammatory cytokines and fluid shear stress converge upon and activate lactosylceramide synthase to generate LacCer. In turn, LacCer activates an "oxygen-sensitive" signaling pathway involving superoxides, nitric oxide, p21 Ras GTP loading, kinase cascade, PI3kinase/Akt activation, nuclear factor up-regulation ultimately contributing to phenotypic changes such as cell proliferation, adhesion, migration and angiogenesis. Since dys-regulation of such phenotypic changes constitute a hallmark in several diseases of the cardiovascular system, proliferative disorders such as cancer, polycystic kidney disease and inflammatory diseases, LacCer synthase and LacCer provide novel targets for the development of therapeutics aimed at these health conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077097     DOI: 10.1016/j.bbagen.2007.08.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

Review 1.  The hypothesis on function of glycosphingolipids and ABO blood groups revisited.

Authors:  Jerzy Kościelak
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 3.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  Minimal variation of the plasma lipidome after delayed processing of neonatal cord blood.

Authors:  John M Wentworth; Naiara G Bediaga; Megan A S Penno; Esther Bandala-Sanchez; Komal N Kanojia; Konstantinos A Kouremenos; Jennifer J Couper; Leonard C Harrison
Journal:  Metabolomics       Date:  2018-09-25       Impact factor: 4.290

5.  Astrocyte-derived lactosylceramide implicated in multiple sclerosis.

Authors:  Abdolmohamad Rostami; Bogoljub Ciric
Journal:  Nat Med       Date:  2014-10       Impact factor: 53.440

6.  Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.

Authors:  Tadahiro Kumagai; Takeshi Sato; Shunji Natsuka; Yukito Kobayashi; Dapeng Zhou; Tadashi Shinkai; Satoru Hayakawa; Kiyoshi Furukawa
Journal:  Glycoconj J       Date:  2010-11-06       Impact factor: 2.916

Review 7.  Mycobacterium tuberculosis and the intimate discourse of a chronic infection.

Authors:  David G Russell
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

8.  The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.

Authors:  Richard L Sidman; Jianxue Li; Matthew Lawrence; Wenzheng Hu; Gary F Musso; Ricardo J Giordano; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap
Journal:  Sci Transl Med       Date:  2015-10-14       Impact factor: 17.956

9.  Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.

Authors:  Mi-Jeong Kim; Helen C Wainwright; Michael Locketz; Linda-Gail Bekker; Gabriele B Walther; Corneli Dittrich; Annalie Visser; Wei Wang; Fong-Fu Hsu; Ursula Wiehart; Liana Tsenova; Gilla Kaplan; David G Russell
Journal:  EMBO Mol Med       Date:  2010-07       Impact factor: 12.137

10.  Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.

Authors:  Sumita Mishra; Djahida Bedja; Christine Amuzie; Alberto Avolio; Subroto Chatterjee
Journal:  Biochem Biophys Res Commun       Date:  2015-08-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.